Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Diagnostic Accuracy of GPT-4o and Claude for HEART Score Calculation in Chest Pain (LLM-HEART)

22 czerwca 2026 zaktualizowane przez: Emir Ünal, Marmara University Pendik Training and Research Hospital

Diagnostic Accuracy of Large Language Models (GPT-4o and Claude) in HEART Score Calculation and 30-Day MACE Prediction in Emergency Department Chest Pain Patients: A Prospective Observational Validation Study Against Three-Expert Consensus

This prospective observational diagnostic accuracy study evaluates whether large language models (LLMs) - GPT-4o (OpenAI, gpt-4o-2024-11-20) and Claude (Anthropic, claude-sonnet-4-6) - can accurately calculate HEART scores from unstructured Turkish clinical notes and predict 30-day major adverse cardiac events (MACE) in emergency department patients presenting with non-traumatic chest pain.

The study will enroll 600 consecutive adult patients. For each patient, the same anonymized data (free-text anamnesis, ECG report text, troponin value, and age) will be independently processed by both LLMs via separate API calls with deterministic settings (temperature=0, JSON format). A three-expert consensus HEART score - derived through blinded independent scoring by three emergency medicine physicians with majority-vote adjudication - serves as the reference standard for agreement analysis. Actual 30-day MACE (all-cause death, AMI Type 1/2/4b, unplanned revascularization) determined via national health database and telephone follow-up serves as the outcome for diagnostic accuracy analysis.

A secondary documentation-quality sub-study will quantify how spontaneously Turkish emergency anamnesis notes capture HEART score parameters.

Przegląd badań

Szczegółowy opis

AI SYSTEM SPECIFICATIONS AND PROMPT PROTOCOL Two distinct large language models (LLMs) will be evaluated as index tests: OpenAI GPT-4o (model string: gpt-4o-2024-11-20) and Anthropic Claude (model string: claude-sonnet-4-6). To ensure reproducibility and eliminate stochastic variation, both models will be accessed via standardized API calls using deterministic parameters (temperature = 0, max_tokens = 500, and strict JSON response format). The exact system prompt layout will be locked prior to initialization, and its integrity will be verified using a SHA-256 cryptographic hash. The models will evaluate each patient record independently in zero-shot isolation, with no cross-contamination or conversational history retention between runs.

REFERENCE STANDARD CONSENSUS PROTOCOL The reference standard consists of a structured consensus HEART score established by three independent emergency medicine physicians (each possessing >=3 years of clinical experience and specific training on HEART score criteria). The physicians will review the anonymized clinical charts while remaining strictly blinded to the LLM outputs and the final 30-day MACE outcomes. For each of the 5 HEART components (scored 0, 1, or 2), a majority vote (2/3 agreement) will determine the final component score. In the event of complete disagreement across all three reviewers on a specific component, a fourth independent adjudicator will resolve the tie.

INDETERMINATE RESULTS MANAGEMENT

In strict compliance with STARD-AI 2025 guidelines, cases with missing or uninterpretable parameters within the free-text clinical notes will be classified into predefined indeterminate tiers:

  1. Complete Cases: 0 indeterminate components (eligible for primary diagnostic accuracy analysis).
  2. Partial Indeterminate: Exactly 1 missing component preventing definitive automatic calculation.
  3. Full Indeterminate: >=2 missing components. The proportion of indeterminate classifications will be quantified for both LLMs and evaluated alongside the routine documentation quality of the charts.

STATISTICAL ANALYSIS AND AGREEMENT WEIGHTING Statistical power and sample size calculation are based on the Hanley-McNeil methodology for the Area Under the ROC Curve (AUC). To achieve an expected AUC of 0.85 with a non-inferiority margin of 0.05, a power of 80%, and a two-sided alpha of 0.05, the primary complete-case analysis requires 600 evaluable patients. Accounting for an anticipated 15% indeterminate rate, a total enrollment target of 690 patients is set. Inter-rater agreement between each LLM and the expert consensus will be computed using quadratic weighted Cohen's Kappa for the ordinal total HEART score (0-10) and linear weighted Kappa for individual components (0-2). Diagnostic performance metrics (sensitivity, specificity, PPV, NPV) will be calculated at prespecified binary (>=4) and trimodal thresholds with 95% Wilson confidence intervals. Pairwise comparison of AUC values between GPT-4o and Claude will be executed using the DeLong test.

DATA ANONYMIZATION AND PRIVACY To ensure full compliance with local personal data protection legislation (KVKK), all free-text emergency department notes will undergo strict de-identification. Patient names, institutional ID numbers, precise dates, and specific demographic identifiers will be stripped entirely before formatting the data payload for API transmission.

PATIENT AND PUBLIC INVOLVEMENT BEYANI Patient and public involvement was not applicable to this study as it involves the analysis of routinely collected clinical data.

Typ studiów

Obserwacyjny

Zapisy (Szacowany)

690

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

  • Nazwa: Emir Ünal, Assistant Professor
  • Numer telefonu: +905327766010
  • E-mail: emirunal@gmail.com

Kopia zapasowa kontaktu do badania

Lokalizacje studiów

    • Istanbul
      • Istanbul, Istanbul, Turcja (Türkiye), 34870
        • Rekrutacyjny
        • Marmara University Pendik Training and Research Hospital
        • Kontakt:
        • Pod-śledczy:
          • Emre Kudu
        • Pod-śledczy:
          • Erhan Altunbas
        • Pod-śledczy:
          • Sinan Karacabey

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Nie

Metoda próbkowania

Próbka bez prawdopodobieństwa

Badana populacja

The study population consists of consecutive adult patients presenting with a chief complaint of non-traumatic chest pain to the emergency department of Marmara University Pendik Training and Research Hospital, a tertiary care academic medical center in Istanbul, Turkey. This target population comprises real-world emergency medicine admissions that require acute coronary syndrome risk stratification and evaluation with the HEART score. It excludes individuals presenting with traumatic pain etiologies or acute ST-elevation myocardial infarction (STEMI) requiring immediate, time-critical reperfusion pathways.

Opis

INCLUSION CRITERIA:

  • Age >=18 years
  • Chief complaint of non-traumatic chest pain at the emergency department
  • Written informed consent obtained from the patient or legally authorized representative
  • Availability for 30-day follow-up (reachable by telephone and/or actively registered in the e-Nabiz national health database)

EXCLUSION CRITERIA:

  • Traumatic chest pain etiology
  • ST-elevation myocardial infarction (STEMI) at presentation requiring immediate reperfusion protocol
  • Refusal or subsequent withdrawal of informed consent
  • Inability to complete the mandatory 30-day follow-up period

WITHDRAWAL CRITERIA:

  • Patient or representative requests data withdrawal after initial consent
  • Administrative identification of retrospective data entry after enrollment

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Area Under the ROC Curve (AUC) of GPT-4o and Claude HEART Score for 30-Day MACE Prediction
Ramy czasowe: 30 days after index emergency department visit
AUC calculated separately for GPT-4o and Claude using the Hanley-McNeil method. MACE is defined as a composite of all-cause death, acute myocardial infarction (Type 1/2/4b), and unplanned revascularization within 30 days. HEART score range is 0-10; a higher score indicates a higher risk of MACE. Analysis will be performed on complete cases only (0 indeterminate components).
30 days after index emergency department visit

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Sensitivity and Specificity of GPT-4o and Claude HEART Score at Prespecified Thresholds
Ramy czasowe: 30 days after index emergency department visit
Diagnostic sensitivity and specificity calculated at two threshold types: (a) total score >=4 (binary high-risk cutoff) and (b) trimodal cutoffs (0-3 low risk, 4-6 intermediate risk, 7-10 high risk). Metrics will be reported with 95% Wilson confidence intervals separately for each LLM.
30 days after index emergency department visit
Component-Level and Total-Score Agreement (Cohen's Kappa) Between LLMs and Expert Consensus
Ramy czasowe: Baseline (At index emergency department visit)
Inter-rater agreement will be computed using quadratic weighted Cohen's Kappa for the ordinal total HEART score (range 0-10) and linear weighted Kappa for the individual components (range 0-2). Calculated separately for GPT-4o vs. expert consensus and Claude vs. expert consensus. Values will be interpreted using the Landis & Koch scale (<0.20 poor, 0.21-0.40 fair, 0.41-0.60 moderate, 0.61-0.80 good, >0.80 excellent).
Baseline (At index emergency department visit)
Comparative AUC Difference Between GPT-4o and Claude (DeLong Test)
Ramy czasowe: 30 days after index emergency department visit
Statistical comparison of paired ROC curves between GPT-4o and Claude using the DeLong et al. (1988) method. The formal hypothesis is non-inferiority with an expected delta AUC <= 0.05. The correlation coefficient between the paired LLM measurements is estimated as rho >= 0.70.
30 days after index emergency department visit
Proportion of Indeterminate Results for GPT-4o and Claude
Ramy czasowe: Baseline (At index emergency department visit)
The proportion of cases classified into predefined missing data tiers: Complete (0 indeterminate components), Partial indeterminate (exactly 1 missing component preventing definitive score calculation), and Full indeterminate (>=2 missing components). Reported separately for each LLM and statistically compared between the two models.
Baseline (At index emergency department visit)
HEART Parameter Documentation Rate in Routine Turkish Anamnesis Notes
Ramy czasowe: Baseline (At index emergency department visit)
For each of the 5 individual HEART components, the proportion of emergency department free-text anamnesis notes that spontaneously contain sufficient objective clinical information for scoring. Rates will be categorized as: Present and scorable, Partiall
Baseline (At index emergency department visit)
Subgroup AUC by Age Group and Sex (Algorithmic Bias Assessment)
Ramy czasowe: 30 days after the index emergency department visit
AUC values for 30-day MACE prediction were calculated separately across demographic strata: age groups (<45, 45-64, >=65 years) and biological sex (male vs. female). This analysis serves as the formal algorithmic bias assessment required by the STARD-AI 2025 guidelines.
30 days after the index emergency department visit

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Publikacje ogólne

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

1 czerwca 2026

Zakończenie podstawowe (Szacowany)

1 marca 2027

Ukończenie studiów (Szacowany)

1 czerwca 2027

Daty rejestracji na studia

Pierwszy przesłany

27 maja 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

3 czerwca 2026

Pierwszy wysłany (Rzeczywisty)

4 czerwca 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

23 czerwca 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

22 czerwca 2026

Ostatnia weryfikacja

1 czerwca 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAK

Opis planu IPD

Anonymized individual participant data (including de-identified baseline demographics, clinical presentation characteristics, index test outputs from GPT-4o and Claude, and the reference standard expert consensus HEART scores) will be made publicly available to support academic transparency and replication. Additionally, the complete deterministic system prompt texts (verified with SHA-256 cryptographic hashes) and the complete statistical analysis code will be included as supplementary material.

Ramy czasowe udostępniania IPD

The anonymized dataset, protocol documents, and analytic code will be made available immediately upon formal publication of the study results.

Kryteria dostępu do udostępniania IPD

Data and code will be accessible via an open-access repository on the Open Science Framework (OSF) for researchers and clinicians interested in replication or meta-analysis.

Typ informacji pomocniczych dotyczących udostępniania IPD

  • PROTOKÓŁ BADANIA
  • SOK ROŚLINNY
  • ANALITYCZNY_KOD

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj